Package 0781-3491-94

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 0781-3491-94
Digits Only 0781349194
Product NDC 0781-3491
Product ID 0781-3491_bf6cb4b7-d4ec-4124-862c-aaa6a32da511
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-3491-94)

Marketing

Marketing Status
Marketed Since 2024-11-01
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "bf6cb4b7-d4ec-4124-862c-aaa6a32da511", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0307813491941"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["7f89fcbd-d3f4-4112-8733-69baea41255e"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-3491-94)", "package_ndc": "0781-3491-94", "marketing_start_date": "20241101"}], "brand_name": "Azacitidine", "product_id": "0781-3491_bf6cb4b7-d4ec-4124-862c-aaa6a32da511", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0781-3491", "generic_name": "Azacitidine", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA212580", "marketing_category": "ANDA", "marketing_start_date": "20240516", "listing_expiration_date": "20261231"}